ncRNAs-mediated overexpression of TET3 predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer

ncRNAs-mediated overexpression of TET3 predicts unfavorable prognosis and correlates with immunotherapy efficacy in breast cancer

Breast cancer is the most frequent form of cancer in women and the primary cause of cancer-related deaths globally. DNA methylation and demethylation are important processes in human tumorigenesis. Ten-eleven translocation 3 (TET3) is a DNA demethylase. Prior research has demonstrated that TET3 is h...

Full description

Bibliographic Details
Main Authors:	Yiyuan Liu, Jinyao Wu, Lingzhi Chen, Juan Zou, Qiuping Yang, Huiting Tian, Daitian Zheng, Zeqi Ji, Jiehui Cai, Zhiyang Li, Yexi Chen
Format:	Article
Language:	English
Published:	Elsevier 2024-02-01
Series:	Heliyon
Subjects:	TET3 Breast cancer Prognosis biomarker ceRNA Tumor immune microenvironment Cancer immunotherapy
Online Access:	http://www.sciencedirect.com/science/article/pii/S2405844024008867

Similar Items

A scientometric analysis of research trends on targeting mTOR in breast cancer from 2012 to 2022
by: Xizhou Zhang, et al.
Published: (2023-08-01)

Global trends in BRCA-related breast cancer research from 2013 to 2022: A scientometric analysis
by: Yujie Huang, et al.
Published: (2023-07-01)

The lost battalion of TET : breakout of the 2/12 cavalry at hue /
by: 219345 Krohn, Charles A.
Published: (2008)

TET1 inhibits the migration and invasion of cervical cancer cells by regulating autophagy
by: Ji Ren, et al.
Published: (2024-12-01)

High C1QTNF1 expression mediated by potential ncRNAs is associated with poor prognosis and tumor immunity in kidney renal clear cell carcinoma
by: Jiechuan Qiu, et al.
Published: (2023-07-01)

The up-regulation of PAK2 indicates unfavorable prognosis in patients with serous epithelial ovarian cancer and contributes to paclitaxel resistance in ovarian cancer cells
by: Ting Shuang, et al.
Published: (2024-09-01)

Trends in research of exosomes associated with breast cancer over the past decade: a scientometric analysis
by: Jiaxin Wu, et al.
Published: (2023-10-01)

ncRNAs-mediated overexpression of STIL predict unfavorable prognosis and correlated with the efficacy of immunotherapy of hepatocellular carcinoma
by: Longwen Xu, et al.
Published: (2023-03-01)

Promoter hypermethylation and comprehensive regulation of ncRNA lead to the down-regulation of ZNF880, providing a new insight for the therapeutics and research of colorectal cancer
by: Xiangqian Dong, et al.
Published: (2023-06-01)

Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 − metastatic or advanced breast cancer patients: a network meta-analysis
by: Yiyuan Liu, et al.
Published: (2023-08-01)

circICMT upregulates and suppresses the malignant behavior of bladder cancer
by: Xin Luo, et al.
Published: (2025-02-01)

Long noncoding RNAs predict the survival of patients with colorectal cancer as revealed by constructing an endogenous RNA network using bioinformation analysis
by: Hui Zhang, et al.
Published: (2019-03-01)

CircTSN promotes the proliferation and metastasis of gastric cancer through the miR-1825/SLC38A2 signaling axis
by: Xuqiang Dong, et al.
Published: (2024-10-01)

Circ_0003945: an emerging biomarker and therapeutic target for human diseases
by: Xiaofei Zhang, et al.
Published: (2024-04-01)

Identification of pivotal lncRNAs in papillary thyroid cancer using lncRNA–mRNA–miRNA ceRNA network analysis
by: Weiwei Liang, et al.
Published: (2019-09-01)

Recent advances of NEAT1-miRNA interactions in cancer
by: Zhou Hui, et al.
Published: (2022-02-01)

Global trends in research of endoscopic thyroidectomy from 2013 to 2022: a scientometric and visualization analysis
by: Daitian Zheng, et al.
Published: (2023-08-01)

Screening and bioinformatics analysis of a ceRNA network based on the circular RNAs, miRNAs, and mRNAs in pan‐cancer
by: Zhanghan Chen, et al.
Published: (2020-10-01)

Cuproptosis-related ceRNA axis triggers cell proliferation and cell cycle through CBX2 in lung adenocarcinoma
by: Jiang Wu, et al.
Published: (2024-02-01)

Non-coding RNAs and exosomal ncRNAs in colorectal cancer
by: Yalda Zhoulideh
Published: (2025-02-01)

Tumour suppressor TET2 safeguards enhancers from aberrant DNA methylation and epigenetic reprogramming in ERα-positive breast cancer cells
by: Ruitu Lyu, et al.
Published: (2022-10-01)

Hypoxia-driven ncRNAs in breast cancer
by: Hashim H. Al-Zuaini, et al.
Published: (2023-07-01)

Identification of novel tetracycline resistance gene tet(X14) and its co-occurrence with tet(X2) in a tigecycline-resistant and colistin-resistant Empedobacter stercoris
by: Yingying Cheng, et al.
Published: (2020-01-01)

Circular RNAs in cancer: roles, mechanisms, and therapeutic potential across colorectal, gastric, liver, and lung carcinomas
by: Ayushi Malviya, et al.
Published: (2025-01-01)

Identification of MYC and STAT3 for early diagnosis based on the long noncoding RNA-mRNA network and bioinformatics in colorectal cancer
by: Kunhou Yao, et al.
Published: (2025-01-01)

Tweety homolog 3 promotes colorectal cancer progression through mutual regulation of histone deacetylase 7
by: Pengyan Lu, et al.
Published: (2024-06-01)

Exploring the key genes associated with breast cancer radiotherapy sensitivity based on the stromal-immune score and analysis of the WGCNA and ceRNA network
by: Xiaoyue Sun, et al.
Published: (2024-07-01)

microRNA 21 and long non-coding RNAs interplays underlie cancer pathophysiology: A narrative review
by: Roberta Giordo, et al.
Published: (2024-09-01)

Integrated analysis of lymphocyte infiltration-associated lncRNA for ovarian cancer via TCGA, GTEx and GEO datasets
by: Meijing Wu, et al.
Published: (2020-05-01)

Characterization of ceRNA network to reveal potential prognostic biomarkers in triple-negative breast cancer
by: Xiang Song, et al.
Published: (2019-09-01)

LINC00665: An Emerging Biomarker for Cancer Diagnostics and Therapeutics
by: Chenming Zhong, et al.
Published: (2022-05-01)

UCA1 executes an oncogenic role in pancreatic cancer by regulating miR-582-5p/BRCC3
by: Xiaole Hu, et al.
Published: (2023-07-01)

Transposons Acting as Competitive Endogenous RNAs: In-Silico Evidence from Datasets Characterised by L1 Overexpression
by: Mauro Esposito, et al.
Published: (2022-12-01)

Tetracycline resistance mediated by tet efflux pumps in clinical isolates of Acinetobacter baumannii
by: Maryam Beheshti, et al.
Published: (2020-11-01)

Functional analysis of lncRNAs based on competitive endogenous RNA in tongue squamous cell carcinoma
by: Yidan Song, et al.
Published: (2019-05-01)

The Implications of ncRNAs in the Development of Human Diseases
by: Elena López-Jiménez, et al.
Published: (2021-02-01)

Scientometric analysis of lipid metabolism in breast neoplasm: 2012–2021
by: Xiaobing Lin, et al.
Published: (2023-04-01)

Pan-cancer analyses reveal the molecular and clinical characteristics of TET family members and suggests that TET3 maybe a potential therapeutic target
by: Chunyan Zhang, et al.
Published: (2024-07-01)

The Emerging Roles and Clinical Potential of circSMARCA5 in Cancer
by: Changning Xue, et al.
Published: (2022-09-01)

Vitamin C in combination with inhibition of mutant IDH1 synergistically activates TET enzymes and epigenetically modulates gene silencing in colon cancer cells
by: Christian Gerecke, et al.
Published: (2020-03-01)